(9) When combined, these peptides appear to exert a synergistic action on the pituitary gland, which might result in enhanced growth hormone production
Current Therapeutic Research 1981;30(5):753-764
Introduction Aetna covers GLP-1 medications in 2026, but coverage depends on the specific plan, the indication (diabetes vs obesity vs cardiovascular vs OSA), and whether your employer carved out weight-loss drugs
Those who continued on the 12 mg dose to 104 weeks lost an average of 30.3% of their body weight (approximately 85.0 lbs / 38.6 kg) and importantly, weight loss continued without an obvious plateau, suggesting that durability over time may be achievable with continued treatment
Our clinic explains what is typical, what requires focus, and what might get better with small changes
Offer a non-stimulant alternative to traditional weight loss medications